Dutch Pharma/Medical Supply Issues Conf

6 October 1996

HCP Health Care Projects BV is organizing a seminar on JOZ, said to be the most important document coming from the Dutch Ministry of Health, in which it gives an overview of costs and finances of the country's health care in 1997. The meeting will be held Thursday October 10 at the Golden Tulip Hotel, in Zoetermeer near The Hague.

The seminar will focus on pharmaceutical and medical supply issues. Both are very hot topics as new pharmaceuticals are not accepted in the GVS reimbursement system (Marketletters passim) and the Ministry plans to budget medical supplies.

For further details on this meeting and registration, please contact Harry van der Schoor at HCP Health Care Projects BV, Verhutstiaan 18A, 3723 JRT Bilthoven, The Netherlands. Phone: +31 (0)30 2285261; fax: +31 (0)30 2251671; E-mail: hcp.bilthoven@pi.net.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight